Familial hypercholesterolemia (FH) is a genetic condition that can wreak havoc on heart health, and the guidelines surrounding it are a mix of clarity and confusion.
Here’s the deal: while some organizations are on board with identifying FH through screening, others are dragging their feet. The American Heart Association says, “Hey, let’s screen kids aged 9 to 11.” But then the U.S. Preventive Services Task Force swoops in, claiming there’s not enough evidence to back universal lipid screening for kids and teens under 20. Confusing, right?
Meanwhile, if you’re an adult with an LDL over 190 mg/dL and a family history of early heart disease, the UK’s NICE says to check your family’s medical records. If you’ve got FH, this could save you from a heart attack.
Adults with an LDL over 190 mg/dL and a family history of early heart disease should investigate their family’s health records for FH.
But hold on! Just because you don’t fit neatly into these criteria doesn’t mean you’re in the clear. The Simon-Broome and Dutch Criteria are here to help, but they aren’t foolproof. The Dutch Criteria for FH serves as a valid screening and diagnostic tool, which is crucial for early identification.
Let’s talk about genetic testing. Sure, it’s recommended for affected individuals to screen their relatives, but it’s not a universal fix. The guidelines are somewhat picky. They focus on known familial variants, leaving many potential cases in the dark.
It’s a classic case of “you can’t see the forest for the trees.” Cascade screening is a good idea, but only if your first-degree relatives are available. If they’re not? Tough luck; second-degree relatives might get a shot.
